Dearborn Heights Pharmacist Pleads Guilty in $3 Million Health Care Fraud Case

Mohammad Hamdan admitted to submitting false prescription claims over a five-year period.

Published on Feb. 25, 2026

Got story updates? Submit your updates here. ›

A Dearborn Heights pharmacy owner, Mohammad Hamdan, has pleaded guilty to a federal charge of conspiracy to commit health care fraud. Hamdan admitted to using his two pharmacies to submit over $3 million in false or fraudulent prescription claims to Medicare, Medicaid, and Blue Cross Blue Shield of Michigan over a five-year period. In some cases, the billed medications were not even in the pharmacy's inventory.

Why it matters

Health care fraud schemes like this one can drive up costs for patients and insurance providers, and undermine the integrity of the health care system. The case highlights the importance of oversight and enforcement to prevent such fraudulent activities.

The details

Hamdan, 44, pleaded guilty to the federal charge in court on Tuesday. Prosecutors said he admitted to submitting false or fraudulent prescription claims, including for medications that were not actually in the pharmacy's inventory. The scheme resulted in over $3 million in losses to Medicare, Medicaid, and Blue Cross Blue Shield of Michigan.

  • Hamdan pleaded guilty on Tuesday, February 25, 2026.
  • The fraudulent scheme took place over a five-year period.

The players

Mohammad Hamdan

A 44-year-old Dearborn Heights pharmacy owner who pleaded guilty to conspiracy to commit health care fraud.

U.S. Attorney's Office for the Eastern District of Michigan

The federal prosecutors who brought the charges against Hamdan.

Department of Health and Human Services, Office of the Inspector General

One of the investigating agencies in the case.

Federal Bureau of Investigation

One of the investigating agencies in the case.

Got photos? Submit your photos here. ›

What’s next

A sentencing date for Hamdan has not yet been set.

The takeaway

This case highlights the importance of vigilance and enforcement against health care fraud schemes, which can drive up costs for patients and insurers and undermine the integrity of the health care system.